Proactive Investors - Run By Investors For Investors

Tidal Royalty set to file registration statement with SEC; looks to reinstate shares on OTC

Tidal Royalty is hopeful its common shares will resume trading on the OTC Markets before the end of the year, it said
Tidal Royalty set to file registration statement with SEC; looks to reinstate shares on OTC
Tidal Royalty gave an update today on the trading on the OTC listing situation

Tidal Royalty Corp. (CSE:RLTY, OTC:TDRYF) is looking to reinstate its shares on the OTC markets through filing a registration statement with the U.S. securities regulatory authority.

As reported on September 11, after the close on September 10, the OTC ceased listing the shares under the symbol TDRYF due to an issue with the firm's predecessor.

"Tidal Royalty is working to prepare a registration statement on Form 20-F that it expects will rectify the historical filing deficiencies of the predecessor entity and permit FINRA (the Financial Industry Regulatory Authority that regulates the OTC Markets) to reinstate Tidal Royalty's eligibility for quotation on the OTC Markets," it said in a brief statement today.

Hopeful

"Tidal Royalty is hopeful its common shares will resume trading on the OTC Markets before the end of the year."

Paul Rosen, the chairman of  Tidal Royalty Corp. said on Thursday: "We are committed to rectifying the filing delinquencies of the predecessor company and to reinstate our listing on the OTC Markets.

"In the meantime, our stock continues to trade on the CSE."

 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full RLTY.U profile View Profile

Tidal Royalty Corp. Timeline

Related Articles

data graphic
March 22 2019
The Toronto company is busy meeting what it says is significant demand by building a data asset covering the medical cannabis sector
cannabis leaf
May 08 2019
The company plans to leverage its portfolio of brands as well as its distribution network of more than 39,000 European pharmacies to maximize margins and profitability
medicinal cannabis concept
January 30 2019
Zelda has released its December quarterly report confirming multiple trials are on track.
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use